Instructions for use and dosage instructions for lenvatinib (Lenvatinib) in India

With the popularity of generic drugs of Lenvatinib in India, it has brought a new, more affordable and effective treatment option to many cancer patients. To ensure the safety and effectiveness of this drug in treatment, correct use and precise dosage adjustment are particularly important.

The recommended dosage of lenvatinib monotherapy in India varies for different types of cancer. For patients with local recurrence or metastasis, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC), it is recommended to take 24 mg orally daily. For patients with unresectable hepatocellular carcinoma (HCC), the dose needs to be adjusted according to body weight: patients weighing 60kg and above take 12 mg orally daily; patients weighing less than 60kg take 8 mg orally daily.

In combination therapy, Indian lenvatinib also showed excellent efficacy. For patients with advanced endometrial cancer (EC) who are not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR), and patients with advanced renal cell carcinoma (RCC), when combined with pembrolizumab, the recommended dose is 20 mg orally daily; when combined with everolimus, the recommended dose for patients with RCC is adjusted to 18 mg orally daily.

Of particular note, in patients with impaired renal or hepatic function, the daily dose may need to be adjusted on a case-by-case basis. Therefore, before starting to use Indian Lenvatinib, patients should undergo a comprehensive physical examination and inform their doctor in detail about their physical condition and medication history.

In terms of administration method, Indian lenvatinib should be taken orally at a fixed time every day. Patients can take it on an empty stomach or with food. The medicine should be swallowed whole. If swallowing is difficult, it can be mixed with a tablespoon of water or apple juice. If the patient misses a dose and cannot take it within 12 hours, there is no need to take the next dose at the regular time.

In summary, Indian lenvatinib, as an affordable anti-tumor drug, plays a pivotal role in cancer treatment. However, its use must strictly follow the doctor's instructions and pay attention to dosage adjustment and monitoring of adverse reactions to ensure the safety and effectiveness of the treatment. The mainstream lenvatinib generic drug produced by NATCO in India currently on the market has various specifications and affordable prices. Patients should consider it based on their own needs and economic status when choosing. But no matter which version you choose, you must purchase it through formal channels to ensure the quality of the medicine and the safety of medication.